acetylcysteine has been researched along with quinine in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (62.50) | 29.6817 |
| 2010's | 3 (37.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Jongsakul, K; Ruangvirayuth, R; Watt, G | 1 |
| Ansorena, E; Cenarruzabeitia, E; Iraburu, MJ; López-Zabalza, MJ; Montiel-Duarte, C | 1 |
| Arreesrisom, P; Dondorp, AM; Looareesuwan, S; Udomsangpetch, R | 1 |
1 review(s) available for acetylcysteine and quinine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for acetylcysteine and quinine
| Article | Year |
|---|---|
A pilot study of N-acetylcysteine as adjunctive therapy for severe malaria.
Topics: Acetylcysteine; Adjuvants, Pharmaceutic; Adult; Antimalarials; Double-Blind Method; Humans; Interferon-gamma; Interleukin-10; Interleukin-6; Lactic Acid; Malaria; Male; Pilot Projects; Prospective Studies; Quinine; Statistics, Nonparametric; Time Factors; Tumor Necrosis Factor-alpha | 2002 |
6 other study(ies) available for acetylcysteine and quinine
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Role of reactive oxygen species, glutathione and NF-kappaB in apoptosis induced by 3,4-methylenedioxymethamphetamine ("Ecstasy") on hepatic stellate cells.
Topics: Acetylcysteine; Animals; Apoptosis; Buthionine Sulfoximine; Cells, Cultured; Drug Interactions; Glutathione; Hepatocytes; N-Methyl-3,4-methylenedioxyamphetamine; NF-kappa B; Oxidative Stress; Quinine; Rats; Reactive Oxygen Species; Stellate Ganglion; Vitamin K 3 | 2004 |
Suppressive effects of the anti-oxidant N-acetylcysteine on the anti-malarial activity of artesunate.
Topics: Acetylcysteine; Animals; Antimalarials; Antioxidants; Artemisinins; Artesunate; Drug Interactions; Humans; Parasitic Sensitivity Tests; Plasmodium falciparum; Quinine; Sesquiterpenes | 2007 |